Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia

by Joan Carles Escolà-Gil, Josep Julve, Àfrica Marzal-Casacuberta, Jordi Ordóñez-Llanos, Francesc González-Sastre, Francisco Blanco-Vaca
Published 2000-08-01

ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance

by Joan Carles Escolà-Gil, Josep Julve, Àfrica Marzal-Casacuberta, Jordi Ordóñez-Llanos, Francesc González-Sastre, Francisco Blanco-Vaca
Published 2001-02-01

Mechanisms of HDL deficiency in mice overexpressing human apoA-II

by Josep Julve, Joan Carles Escolà-Gil, Vicent Ribas, Francesc González-Sastre, Jordi Ordóñez-Llanos, José Luis Sánchez-Quesada, Francisco Blanco-Vaca
Published 2002-10-01

ApoA-IMALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia

by Jesús M. Martín-Campos, Josep Julve, Joan Carles Escolà, Jordi Ordóñez-Llanos, Joaquin Gómez, Jaume Binimelis, Francesc González-Sastre, Francisco Blanco-Vaca
Published 2002-01-01

Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-spe...

by Joan Carles Escolà-Gil, Àfrica Marzal-Casacuberta, Josep Julve-Gil, Brian Y. Ishida, Jordi Ordóñez-Llanos, Lawrence Chan, Francesc González-Sastre, Francisco Blanco-Vaca
Published 1998-02-01